4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-22-022683
EVP and General Counsel sold 33,798 shares at an average $77.89 ($2,632,594)
- EVP and General Counsel acquired 28,558 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise | +11,154 | $38.43 | $428,648 | 51,789 | D: show line 1 in the form |
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise | +14,231 | $41.64 | $592,579 | 66,020 | D: show line 2 in the form |
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise | +3,173 | $56.57 | $179,497 | 69,193 | D: show line 3 in the form |
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Sale | −27,769 | $77.76 | $2,159,317 | 41,424 | D: show line 4 in the form |
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Sale | −6,029 | $78.50 | $473,277 | 35,395 | D: show line 5 in the form |
| Open-market sales · 33,798 sh · avg $77.89 · $2,632,594 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise · Non-qualified Stock Option (Right to Buy) | −11,154 | 3,464 | D: show line 6 in the form | |||||
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise · Non-qualified Stock Option (Right to Buy) | −14,231 | 4,213 | D: show line 7 in the form | |||||
| Basil Michelle L EVP and General Counsel | 2022-09-15 | Option exercise · Non-qualified Stock Option (Right to Buy) | −3,173 | 13,564 | D: show line 8 in the form |
Loading xslF345X03/form4.xml…